Tech Company Financing Transactions

Paradigm Spine Funding Round

Paradigm Spine secured a $4.9 million financing round on 3/31/2012. Backers included HealthCor Partners, Robin Hood Ventures and Trevi Health Ventures.

Transaction Overview

Company Name
Announced On
3/31/2012
Transaction Type
Venture Equity
Amount
$4,852,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
505 Park Ave. 14th Floor
New York, NY 10022
USA
Email Address
Overview
Paradigm Spine is a provider of non-fusion spinal implant solutions that serve to address the unmet clinical needs of spine surgeons and their patients. Starting with the coflex interspinous implant technology Paradigm Spine develops a full non-fusion product portfolio of motion preserving, tissue sparing technologies.
Profile
Paradigm Spine LinkedIn Company Profile
Social Media
Paradigm Spine Company Twitter Account
Company News
Paradigm Spine News
Facebook
Paradigm Spine on Facebook
YouTube
Paradigm Spine on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Marc Viscogliosi
  Marc Viscogliosi LinkedIn Profile  Marc Viscogliosi Twitter Account  Marc Viscogliosi News  Marc Viscogliosi on Facebook
Chief Financial Officer
Steve Ward
  Steve Ward LinkedIn Profile  Steve Ward Twitter Account  Steve Ward News  Steve Ward on Facebook
Chief Technical Officer
Francis Magee
  Francis Magee LinkedIn Profile  Francis Magee Twitter Account  Francis Magee News  Francis Magee on Facebook
VP - Marketing
Lisa Denison
  Lisa Denison LinkedIn Profile  Lisa Denison Twitter Account  Lisa Denison News  Lisa Denison on Facebook
VP - Sales
Charlie Gilbride
  Charlie Gilbride LinkedIn Profile  Charlie Gilbride Twitter Account  Charlie Gilbride News  Charlie Gilbride on Facebook
VP - Sales
Timothy Hein
  Timothy Hein LinkedIn Profile  Timothy Hein Twitter Account  Timothy Hein News  Timothy Hein on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/31/2012: Psyadon Pharmaceuticals venture capital transaction
Next: 3/31/2012: Distil Networks venture capital transaction

 

Share this article

 


Where The Data Comes From

Our team works diligently to record every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary